Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Centessa Pharmaceuticals Plc (CNTA) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Centessa Pharmaceuticals Plc. Table 2 shows the detailed insider transactions. This company's CIK number is 1847903.
Total stock buying since 2021: $68,791,201.
Total stock sales since 2021: $24,102,808.
Total stock option exercises since 2021: $3,874,905.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 462,585 | $5,865,195 | 583,037 | $8,755,298 | 298,766 | $1,263,280 |
| 2024 | 0 | $0 | 875,417 | $14,080,183 | 450,313 | $2,455,692 |
| 2023 | 0 | $0 | 120,494 | $558,292 | 37,484 | $155,933 |
| 2022 | 42,500 | $343,744 | 143,123 | $709,035 | 0 | $0 |
| 2021 | 3,301,250 | $62,582,262 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 0 | $0 | 6,000 | $103,380 | 6,000 | $35,040 |
| 2025-07 | 0 | $0 | 103,322 | $1,605,792 | 95,000 | $425,450 |
| 2025-06 | 0 | $0 | 92,000 | $1,211,671 | 92,000 | $378,080 |
| 2025-05 | 462,585 | $5,865,195 | 65,311 | $831,689 | 65,311 | $252,066 |
| 2025-04 | 0 | $0 | 66,742 | $841,437 | 0 | $0 |
| 2025-03 | 0 | $0 | 68,000 | $1,137,783 | 9,500 | $48,515 |
| 2025-02 | 0 | $0 | 114,920 | $1,951,441 | 30,955 | $124,129 |
| 2025-01 | 0 | $0 | 66,742 | $1,072,105 | 0 | $0 |
| 2024-12 | 0 | $0 | 264,125 | $4,609,940 | 127,809 | $678,120 |
| 2024-11 | 0 | $0 | 102,504 | $1,790,701 | 47,504 | $257,522 |
| 2024-10 | 0 | $0 | 66,742 | $1,044,344 | 0 | $0 |
| 2024-09 | 0 | $0 | 301,619 | $4,946,577 | 230,000 | $1,343,200 |
| 2024-08 | 0 | $0 | 85,000 | $1,043,657 | 0 | $0 |
| 2024-03 | 0 | $0 | 51,160 | $610,389 | 45,000 | $176,850 |
| 2024-02 | 0 | $0 | 4,267 | $34,575 | 0 | $0 |
| 2023-09 | 0 | $0 | 37,484 | $235,699 | 37,484 | $155,933 |
| 2023-06 | 0 | $0 | 19,500 | $86,853 | 0 | $0 |
| 2023-05 | 0 | $0 | 14,800 | $65,947 | 0 | $0 |
| 2023-04 | 0 | $0 | 20,100 | $74,187 | 0 | $0 |
| 2023-02 | 0 | $0 | 7,700 | $29,198 | 0 | $0 |
| 2023-01 | 0 | $0 | 20,910 | $66,408 | 0 | $0 |
| 2022-12 | 0 | $0 | 9,400 | $36,744 | 0 | $0 |
| 2022-08 | 0 | $0 | 10,423 | $46,403 | 0 | $0 |
| 2022-07 | 0 | $0 | 29,100 | $143,120 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-15 | Hussain Iqbal J (General Counsel) | Sale | 6,000 | 17.23 | 103,380 |
| 2025-08-15 | Hussain Iqbal J (General Counsel) | Option Ex | 6,000 | 5.84 | 35,040 |
| 2025-07-29 | Accardi Mario Alberto (President, Orexin Program) | Sale | 8,322 | 15.23 | 126,752 |
| 2025-07-25 | Weinhoff Gregory M (Chief Business Officer) | Sale | 10,000 | 15.56 | 155,600 |
| 2025-07-25 | Weinhoff Gregory M (Chief Business Officer) | Option Ex | 10,000 | 3.85 | 38,500 |
| 2025-07-21 | Saha Saurabh (Chief Executive Officer) | Sale | 55,000 | 15.92 | 875,600 |
| 2025-07-21 | Saha Saurabh (Chief Executive Officer) | Option Ex | 55,000 | 3.85 | 211,750 |
| 2025-07-15 | Hussain Iqbal J (General Counsel) | Sale | 18,000 | 14.93 | 268,704 |
| 2025-07-15 | Hussain Iqbal J (General Counsel) | Option Ex | 18,000 | 5.84 | 105,120 |
| 2025-06-25 | Weinhoff Gregory M (Chief Business Officer) | Sale | 10,000 | 13.86 | 138,640 |
| 2025-06-25 | Weinhoff Gregory M (Chief Business Officer) | Option Ex | 10,000 | 3.85 | 38,500 |
| 2025-06-24 | Accardi Mario Alberto (President, Orexin Program) | Sale | 15,000 | 14.00 | 210,000 |
| 2025-06-24 | Accardi Mario Alberto (President, Orexin Program) | Option Ex | 15,000 | 3.85 | 57,750 |
| 2025-06-24 | Hussain Iqbal J (General Counsel) | Sale | 12,000 | 14.02 | 168,216 |
| 2025-06-24 | Hussain Iqbal J (General Counsel) | Option Ex | 12,000 | 5.84 | 70,080 |
| 2025-06-20 | Saha Saurabh (Chief Executive Officer) | Sale | 55,000 | 12.63 | 694,815 |
| 2025-06-20 | Saha Saurabh (Chief Executive Officer) | Option Ex | 55,000 | 3.85 | 211,750 |
| 2025-05-27 | Weinhoff Gregory M (Chief Business Officer) | Sale | 10,000 | 12.82 | 128,230 |
| 2025-05-27 | Weinhoff Gregory M (Chief Business Officer) | Option Ex | 10,000 | 3.85 | 38,500 |
| 2025-05-20 | Saha Saurabh (Chief Executive Officer) | Sale | 55,000 | 12.71 | 699,105 |
| 2025-05-20 | Saha Saurabh (Chief Executive Officer) | Option Ex | 55,000 | 3.85 | 211,750 |
| 2025-05-16 | Goyal Arjun (Director) | Buy | 417,646 | 12.73 | 5,314,962 |
| 2025-05-15 | Goyal Arjun (Director) | Buy | 44,939 | 12.24 | 550,233 |
| 2025-05-01 | Hussain Iqbal J (General Counsel) | Sale | 311 | 14.00 | 4,354 |
| 2025-05-01 | Hussain Iqbal J (General Counsel) | Option Ex | 311 | 5.84 | 1,816 |
| 2025-04-25 | Weinhoff Gregory M (Chief Business Officer) | Sale | 11,742 | 13.61 | 159,855 |
| 2025-04-22 | Saha Saurabh (Chief Executive Officer) | Sale | 40,344 | 12.43 | 501,475 |
| 2025-04-21 | Saha Saurabh (Chief Executive Officer) | Sale | 14,656 | 12.29 | 180,107 |
| 2025-03-20 | Saha Saurabh (Chief Executive Officer) | Sale | 55,000 | 16.69 | 918,060 |
| 2025-03-17 | Hussain Iqbal J (General Counsel) | Sale | 6,000 | 16.45 | 98,700 |
| 2025-03-17 | Hussain Iqbal J (General Counsel) | Option Ex | 6,000 | 5.84 | 35,040 |
| 2025-03-17 | Chao David M (Chief Administrative Officer) | Sale | 7,000 | 17.29 | 121,023 |
| 2025-03-17 | Chao David M (Chief Administrative Officer) | Option Ex | 3,500 | 3.85 | 13,475 |
| 2025-02-25 | Weinhoff Gregory M (Chief Business Officer) | Sale | 11,494 | 15.25 | 175,272 |
| 2025-02-20 | Saha Saurabh (Chief Executive Officer) | Sale | 55,000 | 16.23 | 892,705 |
| 2025-02-10 | Anderson Karen M. (Chief People Officer) | Sale | 429 | 18.99 | 8,146 |
| 2025-02-10 | Anderson Karen M. (Chief People Officer) | Option Ex | 429 | 4.01 | 1,720 |
| 2025-02-07 | Anderson Karen M. (Chief People Officer) | Sale | 30,526 | 19.03 | 580,787 |
| 2025-02-07 | Anderson Karen M. (Chief People Officer) | Option Ex | 30,526 | 4.01 | 122,409 |
| 2025-02-03 | Bush Tia L (Chief Technology & Quality Ofc) | Sale | 11,000 | 16.86 | 185,405 |
| 2025-02-03 | Anderson Karen M. (Chief People Officer) | Sale | 6,471 | 16.86 | 109,126 |
| 2025-01-27 | Weinhoff Gregory M (Chief Business Officer) | Sale | 11,742 | 16.47 | 193,425 |
| 2025-01-21 | Saha Saurabh (Chief Executive Officer) | Sale | 55,000 | 15.98 | 878,680 |
| 2024-12-20 | Saha Saurabh (Chief Executive Officer) | Sale | 55,000 | 17.44 | 959,035 |
| 2024-12-17 | Bush Tia L (Chief Technology & Quality Ofc) | Sale | 17,813 | 18.00 | 320,634 |
| 2024-12-17 | Bush Tia L (Chief Technology & Quality Ofc) | Option Ex | 17,813 | 3.85 | 68,580 |
| 2024-12-17 | Anderson Karen M. (Chief People Officer) | Sale | 10,624 | 17.32 | 184,039 |
| 2024-12-17 | Anderson Karen M. (Chief People Officer) | Option Ex | 10,624 | 3.85 | 40,902 |
| 2024-12-16 | Bush Tia L (Chief Technology & Quality Ofc) | Sale | 9,611 | 16.36 | 157,255 |
| 2024-12-16 | Hussain Iqbal J (General Counsel) | Sale | 77,705 | 16.39 | 1,273,740 |
| 2024-12-16 | Hussain Iqbal J (General Counsel) | Option Ex | 6,000 | 5.84 | 35,040 |
| 2024-12-13 | Anderson Karen M. (Chief People Officer) | Sale | 5,876 | 17.01 | 99,974 |
| 2024-12-13 | Anderson Karen M. (Chief People Officer) | Option Ex | 5,876 | 3.85 | 22,622 |
| 2024-12-06 | Saha Saurabh (Chief Executive Officer) | Sale | 87,496 | 18.46 | 1,615,263 |
| 2024-12-06 | Saha Saurabh (Chief Executive Officer) | Option Ex | 87,496 | 5.84 | 510,976 |
| 2024-11-25 | Saha Saurabh (Chief Executive Officer) | Sale | 299 | 18.23 | 5,450 |
| 2024-11-25 | Saha Saurabh (Chief Executive Officer) | Option Ex | 299 | 5.84 | 1,746 |
| 2024-11-25 | Weinhoff Gregory M (Chief Business Officer) | Sale | 10,000 | 17.66 | 176,600 |
| 2024-11-25 | Weinhoff Gregory M (Chief Business Officer) | Option Ex | 10,000 | 3.85 | 38,500 |
| 2024-11-22 | Saha Saurabh (Chief Executive Officer) | Sale | 1,671 | 18.24 | 30,479 |
| 2024-11-22 | Saha Saurabh (Chief Executive Officer) | Option Ex | 1,671 | 5.84 | 9,758 |
| 2024-11-21 | Saha Saurabh (Chief Executive Officer) | Sale | 3,511 | 18.24 | 64,030 |
| 2024-11-21 | Saha Saurabh (Chief Executive Officer) | Option Ex | 3,511 | 5.84 | 20,504 |
| 2024-11-20 | Saha Saurabh (Chief Executive Officer) | Sale | 55,000 | 16.89 | 928,730 |
| 2024-11-13 | Saha Saurabh (Chief Executive Officer) | Sale | 32,023 | 18.28 | 585,412 |
| 2024-11-13 | Saha Saurabh (Chief Executive Officer) | Option Ex | 32,023 | 5.84 | 187,014 |
| 2024-10-25 | Weinhoff Gregory M (Chief Business Officer) | Sale | 11,742 | 15.38 | 180,627 |
| 2024-10-23 | Saha Saurabh (Chief Executive Officer) | Sale | 2,592 | 15.31 | 39,696 |
| 2024-10-22 | Saha Saurabh (Chief Executive Officer) | Sale | 30,203 | 15.67 | 473,160 |
| 2024-10-21 | Saha Saurabh (Chief Executive Officer) | Sale | 22,205 | 15.80 | 350,861 |
| 2024-09-25 | Weinhoff Gregory M (Chief Business Officer) | Sale | 16,619 | 15.69 | 260,718 |
| 2024-09-20 | Saha Saurabh (Chief Executive Officer) | Sale | 55,000 | 16.53 | 908,985 |
| 2024-09-10 | Saha Saurabh (Chief Executive Officer) | Sale | 175,000 | 16.52 | 2,891,874 |
| 2024-09-10 | Saha Saurabh (Chief Executive Officer) | Option Ex | 175,000 | 5.84 | 1,022,000 |
| 2024-09-10 | Weinhoff Gregory M (Chief Business Officer) | Sale | 30,000 | 17.00 | 510,000 |
| 2024-09-10 | Weinhoff Gregory M (Chief Business Officer) | Option Ex | 30,000 | 5.84 | 175,200 |
| 2024-09-09 | Weinhoff Gregory M (Chief Business Officer) | Sale | 25,000 | 15.00 | 375,000 |
| 2024-09-09 | Weinhoff Gregory M (Chief Business Officer) | Option Ex | 25,000 | 5.84 | 146,000 |
| 2024-08-23 | Saha Saurabh (Chief Executive Officer) | Sale | 46,651 | 12.30 | 573,900 |
| 2024-08-23 | Weinhoff Gregory M (Chief Business Officer) | Sale | 17,802 | 12.29 | 218,786 |
| 2024-08-22 | Saha Saurabh (Chief Executive Officer) | Sale | 506 | 12.23 | 6,188 |
| 2024-08-22 | Weinhoff Gregory M (Chief Business Officer) | Sale | 12,198 | 12.17 | 148,425 |
| 2024-08-21 | Saha Saurabh (Chief Executive Officer) | Sale | 3,674 | 12.24 | 44,988 |
| 2024-08-20 | Saha Saurabh (Chief Executive Officer) | Sale | 4,169 | 12.32 | 51,370 |
| 2024-03-25 | Anderson Karen M. (Chief People Officer) | Sale | 51,160 | 11.93 | 610,389 |
| 2024-03-25 | Anderson Karen M. (Chief People Officer) | Option Ex | 45,000 | 3.93 | 176,850 |
| 2024-02-01 | Rotman Harris (SVP Regulatory Affairs) | Sale | 4,267 | 8.10 | 34,575 |
| 2023-09-20 | Rotman Harris (SVP Regulatory Affairs) | Sale | 37,484 | 6.29 | 235,699 |
| 2023-09-20 | Rotman Harris (SVP Regulatory Affairs) | Option Ex | 37,484 | 4.16 | 155,933 |
| 2023-06-01 | Yver Antoine (EVP & Chairman of Development) | Sale | 13,000 | 4.45 | 57,902 |
| 2023-05-24 | Bush Tia L (Chief Quality Officer) | Sale | 8,000 | 4.48 | 35,864 |
| 2023-05-01 | Yver Antoine (EVP & Chairman of Development) | Sale | 6,800 | 4.42 | 30,083 |
| 2023-04-03 | Yver Antoine (EVP & Chairman of Development) | Sale | 13,400 | 3.69 | 49,458 |
| 2023-02-01 | Yver Antoine (EVP & Chairman of Development) | Sale | 7,700 | 3.79 | 29,198 |
| 2023-01-04 | Yver Antoine (EVP & Chairman of Development) | Sale | 13,940 | 3.18 | 44,272 |
| 2022-12-01 | Yver Antoine (EVP & Chairman of Development) | Sale | 9,400 | 3.91 | 36,744 |
| 2022-08-01 | Yver Antoine (EVP & Chairman of Development) | Sale | 10,423 | 4.45 | 46,403 |
| 2022-07-18 | Yver Antoine (EVP & Chairman of Development) | Sale | 20,000 | 4.87 | 97,320 |
| 2022-07-01 | Yver Antoine (EVP & Chairman of Development) | Sale | 9,100 | 5.03 | 45,800 |
| 2022-06-24 | Saha Saurabh (Chief Executive Officer) | Buy | 10,000 | 4.63 | 46,280 |
| 2022-06-17 | Yver Antoine (EVP & Chairman of Development) | Sale | 9,200 | 4.68 | 43,037 |
| 2022-05-18 | Yver Antoine (EVP & Chairman of Development) | Sale | 64,778 | 5.10 | 330,108 |
| 2022-05-17 | Yver Antoine (EVP & Chairman of Development) | Sale | 20,222 | 5.42 | 109,623 |
| 2022-02-02 | Saha Saurabh (Chief Executive Officer) | Buy | 5,000 | 9.74 | 48,700 |
| 2022-01-28 | Grainger David J (Chief Innovation Officer) | Buy | 27,500 | 9.05 | 248,764 |
| 2021-12-02 | Medicxi Growth I Gp Ltd (10% Owner) | Buy | 34,326 | 12.82 | 440,059 |
| 2021-12-02 | De Rubertis Francesco (Director) | Buy | 34,326 | 12.82 | 440,059 |
| 2021-12-01 | Medicxi Growth I Gp Ltd (10% Owner) | Buy | 60,304 | 12.62 | 761,036 |
| 2021-12-01 | De Rubertis Francesco (Director) | Buy | 60,304 | 12.62 | 761,036 |
| 2021-11-30 | Medicxi Growth I Gp Ltd (10% Owner) | Buy | 36,847 | 11.62 | 428,162 |
| 2021-11-30 | De Rubertis Francesco (Director) | Buy | 36,847 | 11.62 | 428,162 |
| 2021-11-29 | Medicxi Growth I Gp Ltd (10% Owner) | Buy | 56,706 | 11.70 | 663,460 |
| 2021-11-29 | De Rubertis Francesco (Director) | Buy | 56,706 | 11.70 | 663,460 |
| 2021-11-26 | Medicxi Growth I Gp Ltd (10% Owner) | Buy | 11,817 | 11.34 | 133,945 |
| 2021-11-26 | De Rubertis Francesco (Director) | Buy | 11,817 | 11.34 | 133,945 |
| 2021-11-18 | Kantoff Aaron (Director) | Buy | 10,000 | 11.98 | 119,850 |
| 2021-11-16 | Bush Tia L (Chief Quality Officer) | Buy | 5,000 | 12.32 | 61,625 |
| 2021-11-16 | Saha Saurabh (Chief Executive Officer) | Buy | 23,000 | 12.28 | 282,463 |
| 2021-06-02 | Bush Tia L (Chief Quality Officer) | Buy | 3,000 | 20.00 | 60,000 |
| 2021-06-02 | Hussain Iqbal J (General Counsel) | Buy | 8,500 | 20.00 | 170,000 |
| 2021-06-02 | Chao David M (Chief Administrative Officer) | Buy | 500 | 20.00 | 10,000 |
| 2021-06-02 | Goyal Arjun (Director) | Buy | 750,000 | 20.00 | 15,000,000 |
| 2021-06-02 | General Atlantic Um B.v. | Buy | 1,500,000 | 20.00 | 30,000,000 |
| 2021-06-02 | Thorell Marella (Chief Accounting Officer) | Buy | 1,000 | 20.00 | 20,000 |
| 2021-06-02 | Medicxi Growth I Gp Ltd (10% Owner) | Buy | 600,000 | 20.00 | 12,000,000 |
| 2021-06-02 | Templeman Thomas (Chief Technology Officer) | Buy | 250 | 20.00 | 5,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of CNTA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Centessa Pharmaceuticals Plc (symbol CNTA, CIK number 1847903) see the Securities and Exchange Commission (SEC) website.